Ziarco Pharma Ltd.
Records under this name other than patents Ziarco Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Ziarco Pharma Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,034,858 | Pharmaceutical Composition for Topical Administration Lapsed on the fee record Ended Jul 31, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 31, 2026 | Medium confidence |
| US 9,693,995 | Pharmaceutical Composition for Topical Administration Lapsed on the fee record Ended Jul 4, 2025 · High confidence | Lapsed on the fee record | Ended Jul 4, 2025 | High confidence |
| US 9,533,989 | Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors Lapsed on the fee record Ended Jan 3, 2025 · USPTO record | Lapsed on the fee record | Ended Jan 3, 2025 | USPTO record |
| US 10,065,964 | Pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors Lapsed on the fee record Ended Sep 4, 2022 · USPTO record | Lapsed on the fee record | Ended Sep 4, 2022 | USPTO record |